Asset Manager

Updated:

BIO-key International

Michael DePasquale leads BIO-key International, a publicly traded IAM firm serving defense and enterprise clients with authentication as a service.

BIO-key International

BIO-key International was founded in 1993 and has been led by Chairman and CEO Michael DePasquale for over two decades, navigating a transition from custom finger-scan hardware to a software-centric provider of multi-factor authentication systems. Originally known for its proprietary fingerprint readers sold to major OEMs, the firm refocused its strategy around 2014, shifting to enterprise identity and access management solutions that unify biometrics with traditional tokens and phone-based push notifications. This pivot aligned BIO-key with regulatory trends in financial services and healthcare, where strong, non- password-reliant authentication became a compliance requirement. The firm's platform, PortalGuard, anchors a suite of IAM tools that serve enterprise, government, and education clients. Deployment models include on-premise installations for air-gapped networks and fully hosted cloud-based authentication-as-a-service. Its customer base has included the U.S. Department of Defense for secure workstation access, as well as large-scale deployments for state agencies like Oklahoma's Office of Management and Enterprise Services. Key partnerships with managed service providers and identity-focused resellers broaden its reach into small and mid-sized organizations that lack in-house identity engineering resources, allowing the firm to serve a broad geography across North America and select international markets. BIO-key operates from its headquarters in Wall, New Jersey, with additional technical operations in Minneapolis, Minnesota, and reports as a publicly traded company on the Nasdaq exchange. The firm has periodically expanded through targeted acquisitions; in May 2023, it acquired Swivel Secure Europe, a Spanish IAM provider, extending its reach into European and Latin American financial-service markets and adding a recurring-revenue base of license-maintenance contracts (per the firm's official communications, 2023). Total headcount is not publicly disclosed, but SEC filings suggest a lean team consistent with its project-based and channel-partner delivery model. BIO-key's structural differentiator is its integration of proprietary biometric algorithms directly into a broadly deployable IAM platform — a rare combination among identity vendors, most of whom rely on third-party operating-system biometrics or resell token-based multi-factor authentication. By embedding fingerprint, palm, and eventually behavioral biometrics within its own authentication infrastructure, the firm aims to solve the interoperability challenge that historically limited biometric adoption to niche high-security facilities. This approach positions it unconventionally between pure-play biometric sensor manufacturers and generalist IAM providers like Okta or Microsoft.

General information

Firm type

Asset Manager

Year founded

1993

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Wall

Corporate office

Wall, NJ, United States

Additional offices

Minneapolis, MN

Principals

Michael DePasquale

Chairman and CEO

Sector focus

CybersecurityEnterprise Software

Frequently asked questions

How does BIO-key generate revenue?

BIO-key generates revenue through multiple streams, including subscription-based authentication-as-a-service contracts, perpetual software license sales, hardware tokens, and professional services for custom identity integrations. The firm has increasingly emphasized recurring revenue, particularly through multi-year government and enterprise contracts and the service agreements acquired with Swivel Secure in 2023.

Which sectors does BIO-key explicitly target for IAM deployments?

BIO-key focuses on sectors with stringent compliance and data-protection requirements. Its historical strength has been in government and defense, including U.S. agencies requiring on-premise, air-gapped solutions. It has also targeted healthcare for electronic prescription and patient-record access control, financial services for PCI and FFIEC compliance, and education for student and faculty secure portal access. The firm does not publicly prioritize general e-commerce or consumer-facing identity verification.

What makes BIO-key's biometrics different from Apple Face ID or Windows Hello?

Unlike consumer-grade biometrics embedded in phone or laptop operating systems, BIO-key's technology is designed for the enterprise IAM stack — it can authenticate across devices, networks, and applications from a single centrally managed identity. Its algorithms are hardware-agnostic, meaning the same finger scan template can interoperate with multiple sensor brands. This contrasts with device-locked biometrics where the template never leaves the local hardware and cannot serve as a unified identity across enterprise systems.

Is BIO-key structured as a venture-scale growth firm or a restrained public company?

BIO-key is a restrained public company. It trades on Nasdaq and files regular financial reports with the SEC, operating with a project- and channel-driven model rather than the cash-burning growth posture of a VC-backed startup. Its acquisition of Swivel Secure was modest and immediately accretive to its European recurring revenue base, consistent with a management style that favors targeted inorganic expansion over speculative scaling.

What is BIO-key's known posture on co-selling alongside larger identity platforms?

BIO-key actively seeks co-sell and technology integration partnerships rather than competing directly against the largest IAM suites. Its PortalGuard platform supports integrations with Microsoft Active Directory and Azure AD, allowing it to augment existing Microsoft-centric environments with biometric authentication. This channel-friendly posture enables it to reach customers that have already standardized on a major platform but need stronger authentication methods.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Wall Asset Manager profiles